Document Detail

Photodynamic therapy as adjunctive therapy for morpheaform basal cell carcinoma.
MedLine Citation:
PMID:  21879201     Owner:  NLM     Status:  In-Data-Review    
The authors decided to evaluate the possible use of methyl-aminolevulinate photodynamic therapy (MAL-PDT) as adjunctive therapy for morpheaform basal cell carcinoma prior to standard surgical excision in order to reduce tumor size and volume and to facilitate surgical treatment. It was observed that MAL-PDT may be an option as an adjunctive therapy prior to standard surgical excision of morpheaform basal cell carcinoma, leading to less invasive surgery.
Tiago Torres; Iolanda Fernandes; Virgílio Costa; Manuela Selores
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Acta dermatovenerologica Alpina, Panonica, et Adriatica     Volume:  20     ISSN:  1581-2979     ISO Abbreviation:  Acta Dermatovenerol Alp Panonica Adriat     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-08-31     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9422563     Medline TA:  Acta Dermatovenerol Alp Panonica Adriat     Country:  Slovenia    
Other Details:
Languages:  eng     Pagination:  23-5     Citation Subset:  IM    
Department of Dermatology, Centro Hospitalar do Porto - Hospital de Santo António, Edifício das Consultas Externas do Hospital Geral Santo António, Ex. CICAP, Rua D. Manuel II, s/n, 4100 Porto, Portugal, E-mail:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Discontinuing long-term Iloprost treatment for Raynaud's Phenomenon and systemic sclerosis: A single...
Next Document:  Tufted hair folliculitis: A case report and literature review.